Describing a Food and Drug Aministration directive to warn consumers about the risk of tardive dyskinesia from drugs such as Haldol, Navane, and Mellaril. Including text of the FDA's statement.
Requests to publish, redistribute, or replicate this material should be addressed to Special Collections and University Archives, University of Massachusetts Amherst Libraries.
Contact host institution for more information.
